|
|
|
By Allan Marinelli and Howard Mann | This is the third article in a series of three articles. It continues the discussion by sharing a generic example of continuous GR&R using Minitab. Study setup, the role of the study director, analysis, and case studies are examined. |
|
|
|
|
|
|
|
|
|
| Risky Assumptions For Addressing Limited Bioavailability | e-book | Thermo Fisher Scientific | Bioavailability challenges are an inherent part of the drug development process. Review some risky assumptions surrounding bioavailability during development and key considerations for addressing them. |
|
|
|
|
|
|
|
| Aseptic Filling: Reducing Risk And Improving Sterility In GMP Manufacturing | Wednesday, January 31, 2024 | 4:00 p.m. GMT / 11:00 a.m. EST / 8:00 a.m. PST | One Hour Join us for an exclusive online joint webinar hosted by Cytiva and Singota Solutions. Connect with industry leaders on Wednesday, January 31, 2024, at 4:00 p.m. GMT / 11:00 a.m. EST / 8:00 a.m. PST for an immersive experience, as we dive deep into Cytiva’s expertise and Singota's top-tier aseptic filling capabilities, and gain insights into reducing risk and improving sterility. Don't miss out on this can't-miss event led by bio and pharma experts. Mark your calendar for a transformative learning experience! Register now |
|
|
Connect With Pharmaceutical Online: |
|
|
|